Stenocare Q2-regnskab - en "swathe" af aktiviteter
-
Danske Stenocare er et af de få selskaber, som er lykkedes med at få medicinsk cannabis godkendt hos forskellige landes lægemiddelstyrelser og få deres produkter på markedet. Selskabet har netop afleveret Q2-regnskab - som overordnet set ser lidt bedre ud end ventet. Det dykker Helge Larsen ned i sammen med CEO Thomas Skovlund Schnegelsberg.
Disclaimer: Stenocare har betalt ir-samarbejde med proinvestor.com. Videoen er ikke en anbefaling om køb eller salg af aktier.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind